Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruyi Jinhuang Powder is a traditional Chinese medicine (TCM) topical formulation composed of multiple herbal ingredients, including *Curcuma longa* (turmeric), *Phellodendron amurense* (Amur cork tree bark), and *Rheum palmatum* (rhubarb). It is traditionally utilized in Chinese medicine for the treatment of skin infections, carbuncles, and localized inflammatory conditions. The formulation is typically prepared as a powder that is mixed with a liquid medium (such as water, tea, or oil) to form a paste for external application. In clinical research, it has been investigated as an adjunct therapy for acute pancreatitis, where it is applied topically to acupoints like Shenque (CV8) to alleviate local inflammation, reduce abdominal pain, and promote the recovery of gastrointestinal function. The powder is manufactured by companies such as Jiangsu 707 Natural Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ruyi jinhuang powder.